Paragon CRT® Contact Lens Asian Brochure

Why Paragon CRT®?

NO GLASSES

SCIENCE

SAFETY

The Paragon CRT® Contact Lens was the first FDA approved Ortho-K lens design.4

Over 1.5 million lenses have been prescribed in over 50 countries worldwide.5

NO DAYTIME CONTACTS

MYOPIA

More Than a Vision Issue, It’s a Major Children’s Health Issue.

ZNL100098E 6/18 Indications: Paragon CRT® (paflufocon B) and Paragon CRT® 100 (paflufocon D) Rigid Gas Permeable Contact Lenses for Corneal Refractive Therapy are indicated for use in the reduction of myopic refractive error in non diseased eyes. Warnings: Incorrect use of contact lenses and lens care products can result in serious injury to the eye. It is essential for the patient to follow the eye care practitioner’s directions and all labeling instructions for proper use of contact lenses and lens care products, including the lens case. Eye problems, including corneal ulcers, can develop rapidly and lead to loss of vision. The risk of ulcerative keratitis has been shown to be greater among wearers of extended wear lenses than among wearers of daily wear lenses. The risk among extended wear lens wearers increases with the number of consecutive days that lenses are worn between removals, beginning with the first overnight use.

This risk can be reduced by carefully following directions for routine lens care, including cleaning of the lens storage case. Additionally, smoking increases the risk of ulcerative keratitis for contact lens wearers. It is recommended that contact lens wearers see their eye care practitioners twice each year or, if directed, more frequently. Note: To maintain the Corneal Refractive Therapy effect of myopia reduction, overnight lens wear must be continued on a prescribed schedule. Failure to do so can affect daily activities (i.e., night driving), visual fluctuations and changes in intended correction. Attention: Please refer to physician labeling for full prescribing information, including detailed directions, proper use, and full risk and safety information. For additional product information see paragonvision.com.

www.ParagonVision.com

ParagonVision.com

MYOPIA

More Than a Vision Issue, It’s a Major Children’s Health Issue!

Learn About the Consequences of Untreated Myopia THE MYOPIA EPIDEMIC Myopia is the medical term for nearsightedness - meaning you can see things close up but not at a distance. Rates of this visual disorder are growing to epidemic proportions.

Myopia may lead to a list of serious short7 and long-term vision complications,8 including:

IMPAIRED ABILITY TO LEARN7

PREMATURE CATARACTS8

GLAUCOMA8

RETINAL DETACHMENT8

WHAT CAUSES MYOPIA The causes of myopia are both genetic and environmental. Increased urbanization and close-range activities such as reading and computer work, may increase the incidence of myopia.7 These factors can cause the eye to elongate, preventing light rays from properly focusing on the back of your child’s retina. These physical changes to the eye cause blurred distance vision symptoms commonly known as nearsightedness.

There Are No Age Restrictions with Paragon CRT®.6 PROTECTING YOUR CHILD’S POTENTIAL Orthokeratology uses specially-designed contact lenses that are worn overnight to manage myopia. When the contact lenses are removed in the morning, children can see clearly without the use of glasses or daytime contacts.9

MYOPIA FACTS In the U.S., the prevalence of nearsightedness (myopia) has increased 66% since 1971.1 It is reported that greater than 80% of urban Asian children suffer from form of nearsightedness (myopia).2 Myopia usually begins in childhood at school age (six years and onwards) and can worsen until early adult years.3

Are Paragon CRT® Contact Lenses Right for You or Your Child?

Visit ParagonVision.com to find a certified eye care professional near you.

1. Vitale S, Sperduto RD, Ferris FL 3rd. Increased Prevalence of Myopia in the U.S. between 1971-1972 and 1999-2004. Arch Ophthalmol. 2009 Dec;127(12):1632-9. PubMed. 2. Pan C-W, Ramamurthy D, Saw S-M. Worldwide prevalence and risk factors for myopia.

Ophthalmic and Physiological Optics. 2012;32(1):3-16. 3. Brien Holden Institute data on file, 2010. 4. FDA Approval Letter. 5. Data on file at Paragon Vision Sciences. 6. Labeling Approved by FDA. 7. Brien Holden Institute data on file, 2010. 8. Xu L, Wang Y, Wang S, Wang Y & Jonas JB, ‘High Myopia and Glaucoma Susceptibility: The Beijing Eye Study’ Ophthalmology, Volume 114, Issue 2, February 2007; Praveen MR,Shah GD, Vasavada AR, Mehta PG, Gilbert C &Bhagat G ‘A study to explore the risk factors for the early onset of cataract in India’, Eye, 24, (12 June 2009). 9. CRT Clinical Study: Takes 7 to 14 days to reach full correction and maintain good vision throughout waking hours. *As of August 2017.